T Lymphocytes (LT) Expressing iCASP9 and ΔCD19 in Allogeneic Haematopoietic Transplantation.

计划入组 2 人 · 首次发布于 2016 年 7 月 29 日

A Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors

计划入组 15 人 · 首次发布于 2024 年 2 月 2 日

Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations

计划入组 32 人 · 首次发布于 2022 年 8 月 12 日

ImmTOR + factor VIII gene therapy (Selecta Biosciences/Spark Therapeutics)

AAV-mediated GABA-selective gene therapy(Encoded)

bicycle radio conjugate select target (cancer)

Daan Gene Co.,Ltd.

China

Select Home Health Care Inc

United States

JIUYUAN GENE

Parse Biosciences Wins Patent Invalidation Case Against 10x Genomics in Single Cell Sequencing Dispute

Cerevance's CVN293 Shows Promise in Phase I Trial for Neurodegenerative Diseases

Parse Biosciences Expands Global Single Cell Sequencing Access Through Strategic Service Provider Partnerships